Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A - Top-Institutions - MDSpire

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A

  • By

  • Michelle R. Lent

  • Emily E. Hurstak

  • Kevin G. Lynch

  • Emily Loscalzo

  • Kimberly Mazur

  • Helen L. Lugo

  • Karen L. Dugosh

  • June 23, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Philadelphia College of Osteopathic Medicine
    Philadelphia College of Osteopathic Medicine

    Philadelphia, PA

    Key Differentiators

    • Addiction Medicine

  • #2

    Public Health Management Corporation
    Public Health Management Corporation

    Philadelphia, PA

    Key Differentiators

    • Public Health

  • #3

    federally qualified health centers (FQHCs)
    federally qualified health centers (FQHCs)

    Various, Various

    Key Differentiators

    • Primary Care
    • Addiction Medicine

  • #4

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, CA

    Key Differentiators

    • Addiction Medicine

  • #5

    University of New Mexico Hospital
    University of New Mexico Hospital

    Albuquerque, NM

    Key Differentiators

    • Addiction Medicine

Original Source(s)

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A

  • by Michelle R. Lent, Emily E. Hurstak, Kevin G. Lynch, Emily Loscalzo, Kimberly Mazur, Helen L. Lugo, Karen L. Dugosh

  • June 23, 2026

Related Content

Augmenting neurocounseling in addiction recovery with intelligent systems: a roadmap for research and practice

Error in the Text

  • June 1, 2026

Case Report: A literature review of the medical complications arising from etomidate-laced vapes and two case studies of hypokalemia associated with etomidate use